Germany: Merck stops development of Parkinson's disease treatment
Germany: Merck stops development of Parkinson's disease treatment
Darmstadt-based Merck said it decided "not to file for approval and not to pursue further development of the compound," known as Sarizotan, which was intended to treat advanced Parkinson's disease patients suffering from dyskinesia, the AP reports.
The setback comes after Merck lost out to Bayer AG in the race to acquire a third German drug maker, Schering AG.
Subscribe to Pravda.Ru Telegram channel, Facebook, RSS!
Popular
Russian military social media began to promote the Sever (North) group of troops of the Russian Armed Forces. The group is known for its tactical sign N and its goal is an offensive on Kharkiv
Last materials